Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes
暂无分享,去创建一个
Kathy Carroll | Andrew Parkinson | Geraldine Hamilton | K. Carroll | G. Hamilton | A. Parkinson | Edward L. LeCluyse | Ajay Madan | Ryan DeHaan | E. LeCluyse | A. Madan | R. DeHaan
[1] Charles W. Dunnett,et al. New tables for multiple comparisons with a control. , 1964 .
[2] A. Conney. Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.
[3] L. Liotta,et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.
[4] P. Thomas,et al. The in vivo turnover of rat liver microsomal epoxide hydrolase and both the apoprotein and heme moieties of specific cytochrome P-450 isozymes. , 1983, Archives of biochemistry and biophysics.
[5] S. Safe,et al. Differential time course of induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by Aroclor 1254. , 1983, Archives of biochemistry and biophysics.
[6] J. Knoben,et al. "Handbook of clinical drug data". , 1983, Canadian Medical Association journal.
[7] P. Watkins,et al. Identification of an inducible form of cytochrome P-450 in human liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Watkins,et al. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. , 1985, Biochemistry.
[9] P. Watkins,et al. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[10] G. Laurie,et al. Basement membrane complexes with biological activity. , 1986, Biochemistry.
[11] P. Beaune,et al. The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. , 1989, British journal of clinical pharmacology.
[12] P. Maurel,et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.
[13] P. Beaune,et al. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. , 1990, European journal of biochemistry.
[14] D. Waxman,et al. Phenobarbital induction of cytochromes P-450. High-level long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response. , 1990, The Biochemical journal.
[15] P. Maurel,et al. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[16] E. Schuetz,et al. Hepatocyte culture in study of P450 regulation. , 1991, Methods in enzymology.
[17] M. Sharratt,et al. Role of persistent, non-genotoxic tissue damage in rodent cancer and relevance to humans. , 1991, Annual review of pharmacology and toxicology.
[18] A. Parkinson,et al. Production and purification of antibodies against rat liver P450 enzymes. , 1991, Methods in enzymology.
[19] Albert P. Li,et al. Isolation and culturing of hepatocytes from human livers , 1992 .
[20] J. Buters,et al. A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. , 1993, Biochemical pharmacology.
[21] J. S. Sidhu,et al. Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2, and 3A1 genes in primary adult rat hepatocyte culture. , 1993, Archives of biochemistry and biophysics.
[22] J. Domergue,et al. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. , 1994, The Journal of pharmacology and experimental therapeutics.
[23] I. Roots,et al. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: Coincidence with plasma clearance and breath test , 1994, Clinical pharmacology and therapeutics.
[24] I. Roots,et al. Specific and dose‐dependent enzyme induction by omeprazole in human beings , 1994, Hepatology.
[25] R. Fisher,et al. Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[26] J. Hochman,et al. Cultured rat hepatocytes. , 1996, Pharmaceutical biotechnology.
[27] Andrew Parkinson,et al. Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes , 1996 .
[28] P. Maurel. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man , 1996 .
[29] A. Parkinson. An Overview of Current Cytochrome P450 Technology for Assessing the Safety and Efficacy of New Materials , 1996, Toxicologic pathology.
[30] A. Parkinson,et al. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. , 1996, Archives of biochemistry and biophysics.
[31] S. Strom,et al. Use of human hepatocytes to study P450 gene induction. , 1996, Methods in enzymology.
[32] C. Bonfils,et al. Effect of cell density and epidermal growth factor on the inducible expression of CYP3A and CYP1A genes in human hepatocytes in primary culture , 1997, Hepatology.
[33] S. Ekins,et al. Examination of purported probes of human CYP2B6. , 1997, Pharmacogenetics.
[34] R Ohlsson,et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] B. Kennedy,et al. Refinement of an in vitro cell model for cytochrome P450 induction. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[36] J. Lehmann,et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.
[37] K. Carroll,et al. Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[38] S. Wrighton,et al. The use of human hepatocyte cultures to study the induction of cytochrome P-450. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[39] A. Li,et al. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. , 1999, Chemico-biological interactions.
[40] L. Moore,et al. The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution , 2000 .